Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Profarmaco
Paullo, Lombardy, Italysiegfried.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Profarmaco is an Italian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs). Founded in Milan, the company established a strong reputation for producing high-quality synthetic APIs for global markets, particularly in therapeutic areas such as central nervous system disorders and respiratory diseases. In 2005, Profarmaco was acquired by the Swiss-based Siegfried Group, a leading global Contract Development and Manufacturing Organization (CDMO). Today, it operates as a key manufacturing site within Siegfried's global network, focusing on complex chemical synthesis and large-scale production. The company provides essential components for both generic and branded pharmaceutical products worldwide.
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Profarmaco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Profarmaco.